Vetoquinol SA banner

Vetoquinol SA
LSE:0O1O

Watchlist Manager
Vetoquinol SA Logo
Vetoquinol SA
LSE:0O1O
Watchlist
Price: 76.8 EUR -0.13% Market Closed
Market Cap: €908.7m

Profitability Summary

Vetoquinol SA's profitability score is 53/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

53 / 100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

53 / 100
Profitability
Score
53 / 100
Profitability
Score

Margins

Earnings Waterfall
Vetoquinol SA

Margins Comparison
Vetoquinol SA Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
FR
Vetoquinol SA
PAR:VETO
906.6m EUR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
908.9B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.1B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.6B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.1B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
277.6B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.2T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
149.7B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
118.9B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Vetoquinol SA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
FR
Vetoquinol SA
PAR:VETO
906.6m EUR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
908.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.6B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.1B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
277.6B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.2T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
149.7B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
118.9B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Vetoquinol SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett